ADAKVEO (crizanlizumab)

**Product type:** Human Prescription Drug

**Active ingredient:** CRIZANLIZUMAB

**Strength:** 10 mg/mL

**Dosage form:** Injection

**Route:** Intravenous

**Labeler:** Novartis Pharmaceuticals Corporation

**Marketing category:** BLA (BLA761128)

**Pharmacologic class:** P-Selectin Blockers [MoA], Selectin Blocker [EPC]